NASDAQ: OGIOrganigram Holdings Inc Stock
$1.93-0.02 (-1.03%)
Updated Apr 24, 2024
OGI Price
$1.93
Fair Value Price
N/A
Market Cap
$156.64M
52 Week Low
$0.97
52 Week High
$2.91
P/E
N/A
P/B
0.82x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.16
Operating Cash Flow
N/A
Beta
1.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OGI Overview
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OGI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OGI is good value based on its book value relative to its share price (0.82x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.06x)
P/B vs Industry Valuation
OGI's short-term assets ($118.73M) exceed its short-term liabilities ($27.75M)
Short-term Liabilities Financials
OGI's short-term assets ($118.73M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more OGI due diligence checks available for Premium users.
Be the first to know about important OGI news, forecast changes, insider trades & much more!
OGI News
Valuation
OGI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
47.66x
Market
41.27x
OGI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.82x
Industry
2.06x
OGI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OGI's financial health
Profit margin
Revenue
$27.4M
Net Income
-$11.9M
Profit Margin
-43.4%
Assets to liabilities
Assets
$224.8M
Liabilities
$31.0M
Debt to equity
0.16
OGI's short-term assets ($118.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OGI's short-term assets ($118.73M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OGI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$5.8M
Investing
$312.8k
Financing
-$114.3k
OGI vs Pharmaceutical Stocks
Organigram Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.